Clinical evaluation of the modified Makari skin test in minimal residual malignant disease.
The results of a double-blind controlled study of the modified Makari skin test in urological malignancy are described. The study suggests that the test will be useful in the monitoring of primary treatment and in the detection of recurrent malignancy and thus indicates a role for the Makari skin test in minimal residual malignant disease.